NIH Study Aims to Identify Promising COVID-19 Treatments for Larger Clinical Trials
October 13, 2020 -- The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today launched a study designed to determine whether certain approved therapies or investigational drugs in late-stage... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - October 13, 2020 Category: Pharmaceuticals Source Type: clinical trials

Moderna Announces Initiation of Rolling Submission to Health Canada for mRNA Vaccine Against COVID-19 (mRNA-1273)
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oct. 13, 2020-- Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - October 13, 2020 Category: Pharmaceuticals Source Type: clinical trials

Vaxart Announces Dosing First Subject in Phase 1 Clinical Trial of Its Oral Tablet COVID-19 Vaccine
SOUTH SAN FRANCISCO, Calif., Oct. 13, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc., (NASDAQ: VXRT), a clinical-stage biotechnology company developing oral vaccines that are administered by tablet rather than by injection, today... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - October 13, 2020 Category: Pharmaceuticals Source Type: clinical trials

Mirikizumab Shows Continued Symptom Improvement and Reduction of Intestinal Inflammation in Patients with Crohn's Disease in 52-Week Phase 2 Trial
INDIANAPOLIS, Oct. 12, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) announced today new efficacy and safety data from the Phase 2 SERENITY study evaluating mirikizumab in patients with moderately to severely active Crohn's... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - October 12, 2020 Category: Pharmaceuticals Source Type: clinical trials

Johnson & Johnson Temporarily Pauses All Dosing in Our Janssen COVID-19 Vaccine Candidate Clinical Trials
October 12, 2020 -- At Johnson& Johnson, there is no greater priority than the safety and well being of the people we serve every day around the world. We are committed to providing transparent updates throughout the clinical development... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - October 12, 2020 Category: Pharmaceuticals Source Type: clinical trials

Avenue Therapeutics Receives Complete Response Letter from the FDA for IV Tramadol
NEW YORK, Oct. 12, 2020 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (NASDAQ: ATXI) (“Avenue”), a company focused on the development of intravenous (“IV”) tramadol for the U.S. market, today announced it has received a... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - October 12, 2020 Category: Pharmaceuticals Source Type: clinical trials

Altimmune And UAB Announce Publication Of Compelling Pre-Clinical Data For AdCOVID ™ Intranasal COVID-19 Vaccine Candidate
GAITHERSBURG, Md., Oct. 12, 2020 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today pre-published a comprehensive preclinical evaluation of its single-dose, intranasal COVID-19... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - October 12, 2020 Category: Pharmaceuticals Source Type: clinical trials

Vir Biotechnology and GSK Announce Global Expansion to Phase 3 of COMET-ICE Study Evaluating VIR-7831 for the Treatment of COVID-19
06 October 2020 -- Vir Biotechnology, Inc. (Nasdaq: VIR) and GlaxoSmithKline plc (LSE/NYSE: GSK) today announced the global expansion to Phase 3 of the COMET-ICE (COVID-19 Monoclonal antibody Efficacy Trial - Intent to Care Early) study evaluating... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - October 12, 2020 Category: Pharmaceuticals Source Type: clinical trials

Pfizer Canada and BioNTech Initiate Rolling Submission to Health Canada for SARS-CoV-2 Vaccine Candidate BNT162b2
KIRKLAND, QUEBEC, CANADA and MAINZ, GERMANY, October 9, 2020 — Pfizer Canada and BioNTech SE (Nasdaq: BNTX) today announced the initiation of a rolling submission to Health Canada for BNT162b2, the lead candidate from... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - October 9, 2020 Category: Pharmaceuticals Source Type: clinical trials

NIH Clinical Trial Testing Hyperimmune Intravenous Immunoglobulin Plus Remdesivir to Treat COVID-19 Begins
October 8, 2020 -- A clinical trial to test the safety, tolerability and efficacy of a combination treatment regimen for coronavirus disease 2019 (COVID-19) consisting of the antiviral remdesivir plus a highly concentrated solution of antibodies... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - October 8, 2020 Category: Pharmaceuticals Source Type: clinical trials

Final Results of National Institute of Allergy and Infectious Diseases ’ ACTT-1 Trial Published in New England Journal of Medicine Expand Clinical Benefits of Veklury® (remdesivir) for the Treatment of COVID-19
FOSTER CITY, Calif.--(BUSINESS WIRE)--Oct. 8, 2020-- The New England Journal of Medicine (NEJM) today published the final results from the National Institute of Allergy and Infectious Diseases’ (NIAID) double-blind,... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - October 8, 2020 Category: Pharmaceuticals Source Type: clinical trials

Lilly Announces Arrangement for Supply of Potential COVID-19 Antibody Therapy for Low- and Middle-Income Countries
INDIANAPOLIS, Oct. 8, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and the Bill& Melinda Gates Foundation, as part of the COVID-19 Therapeutics Accelerator, have entered into an agreement to facilitate access to future Lilly... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - October 8, 2020 Category: Pharmaceuticals Source Type: clinical trials

Merck Announces Week 96 Data from Phase 2b Study Evaluating Islatravir in Combination With Doravirine in Adults With HIV-1 Infection
KENILWORTH, N.J.--(BUSINESS WIRE) October 8, 2020 -- Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced Week 96 data from the Phase 2b trial (NCT03272347) evaluating the efficacy and safety of islatravir, the... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - October 8, 2020 Category: Pharmaceuticals Source Type: clinical trials

Pfizer and Sangamo Dose First Participant in Phase 3 Study Evaluating Hemophilia A Gene Therapy Treatment SB-525
NEW YORK& BRISBANE, Calif.--(BUSINESS WIRE) October 07, 2020 -- Pfizer Inc. (NYSE: PFE) and Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today announced that the first participant has been dosed in the Phase 3 AFFINE... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - October 7, 2020 Category: Pharmaceuticals Source Type: clinical trials

Lilly Provides Comprehensive Update on Progress of SARS-CoV-2 Neutralizing Antibody Programs
INDIANAPOLIS, Oct. 7, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced additional details on its SARS-CoV-2 neutralizing antibody programs– including interim data on combination therapy in recently... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - October 7, 2020 Category: Pharmaceuticals Source Type: clinical trials

BioNTech and Pfizer Initiate Rolling Submission to European Medicines Agency for SARS-CoV-2 Vaccine Candidate BNT162b2
NEW YORK and MAINZ, GERMANY, October 6, 2020 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the initiation of a rolling submission to the European Medicines Agency (EMA) for BNT162b2, the lead candidate from... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - October 6, 2020 Category: Pharmaceuticals Source Type: clinical trials

Oncternal Therapeutics Receives Rare Pediatric Disease Designation from U.S. Food and Drug Administration for TK216 for Treatment of Ewing Sarcoma
SAN DIEGO--(BUSINESS WIRE)--Oct. 6, 2020-- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that the U.S. Food and Drug... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - October 6, 2020 Category: Pharmaceuticals Source Type: clinical trials

Iovance Biotherapeutics Provides Update for Lifileucel in Metastatic Melanoma
SAN CARLOS, Calif., Oct. 05, 2020 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, today provided a regulatory update for... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - October 5, 2020 Category: Pharmaceuticals Source Type: clinical trials

Amgen Announces Positive Topline Phase 2 Results For Investigational KRAS G12C Inhibitor Sotorasib In Advanced Non-Small Cell Lung Cancer
THOUSAND OAKS, Calif., Oct. 5, 2020 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced positive topline Phase 2 results from the CodeBreaK 100 clinical study, evaluating sotorasib (proposed INN for AMG 510) in 126 patients... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - October 5, 2020 Category: Pharmaceuticals Source Type: clinical trials

Regeneron Confirms that REGN-COV2 Antibody Cocktail Provided to President Trump Under Compassionate Use Request
October 2, 2020 --  Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today confirmed that, as announced by the White House Press Secretary, Regeneron provided a single 8 gram dose of REGN-COV2, a cocktail of two monoclonal antibodies, for use by... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - October 2, 2020 Category: Pharmaceuticals Source Type: clinical trials

COVID-19 Vaccine AZD1222 Clinical Trial Resumed in Japan, Follows Restart of Trials in the UK, Brazil, South Africa and India
2 October 2020 -- The Phase I/II clinical trial for the COVID-19 vaccine AZD1222 has resumed in Japan after discussion with the Japanese Pharmaceuticals and Medical Devices Agency (PMDA). A standard review process triggered a voluntary pause to... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - October 2, 2020 Category: Pharmaceuticals Source Type: clinical trials

Gilead Sciences Update on Supply and Distribution of Veklury (remdesivir) in the United States
FOSTER CITY, Calif.--(BUSINESS WIRE)--Oct. 1, 2020-- Since the COVID-19 pandemic began, Gilead has worked diligently to ramp up production and rapidly expand the supply of our investigational antiviral drug Veklury® (remdesivir) by making... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - October 1, 2020 Category: Pharmaceuticals Source Type: clinical trials

Pfizer Receives FDA Fast Track Designation for Duchenne Muscular Dystrophy Investigational Gene Therapy PF-06939926
NEW YORK--(BUSINESS WIRE)--October 01, 2020 -- Pfizer Inc. (NYSE: PFE) today announced that its investigational gene therapy candidate (PF-06939926) being developed to treat Duchenne muscular dystrophy (DMD) received Fast Track designation from the... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - October 1, 2020 Category: Pharmaceuticals Source Type: clinical trials

BioNTech and Pfizer Announce Nature Publication of German Phase 1/2 Study Data from mRNA-based Vaccine Candidate BNT162b1 Against SARS-CoV-2
MAINZ, GERMANY and NEW YORK, September 30, 2020 — BioNTech SE (Nasdaq: BNTX) and Pfizer Inc. (NYSE: PFE) today announced that preliminary, peer-reviewed data from their ongoing German Phase 1/2 Study of BNT162b1 were... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - September 30, 2020 Category: Pharmaceuticals Source Type: clinical trials

CureVac Launches Phase 2a Clinical Trial with COVID-19 Vaccine Candidate
TÜBINGEN, Germany / BOSTON, USA - September 29, 2020 -- CureVac NV (Nasdaq: CVAC), a biopharmaceutical company developing a new class of drugs based on messenger ribonucleic acid (mRNA) in clinical trials, announced today that it is the first... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - September 29, 2020 Category: Pharmaceuticals Source Type: clinical trials

Regeneron's REGN-COV2 Antibody Cocktail Reduced Viral Levels and Improved Symptoms in Non-Hospitalized COVID-19 Patients
TARRYTOWN, N.Y., Sept. 29, 2020 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the first data from a descriptive analysis of a seamless Phase 1/2/3 trial of its investigational antibody cocktail... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - September 29, 2020 Category: Pharmaceuticals Source Type: clinical trials

CTI BioPharma to Submit a New Drug Application (NDA) for the Accelerated Approval of Pacritinib for the Treatment of Myelofibrosis Patients with Severe Thrombocytopenia
SEATTLE, Sept. 29, 2020 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) today announced that following a recent Pre-NDA meeting with the U.S. Food and Drug Administration ( " FDA " or " the Agency " ), the Company has... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - September 29, 2020 Category: Pharmaceuticals Source Type: clinical trials

Moderna Announces Publication in The New England Journal of Medicine of Interim Results From Older Adult Age Cohorts in Phase 1 Study of its mRNA Vaccine Against COVID-19 (mRNA-1273)
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sep. 29, 2020-- Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - September 29, 2020 Category: Pharmaceuticals Source Type: clinical trials

AbbVie Receives Orphan Drug and Fast Track Designations from the U.S. Food and Drug Administration for Elezanumab, an Investigational Monoclonal Antibody RGMa Inhibitor, for the Treatment of Spinal Cord Injury
NORTH CHICAGO, Ill., Sept. 28, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug and Fast Track designations for elezanumab (ABT-555), an investigational... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - September 28, 2020 Category: Pharmaceuticals Source Type: clinical trials

INOVIO Reports FDA Partial Clinical Hold for Planned Phase 2 / 3 Trial of COVID-19 Vaccine Candidate INO-4800
PLYMOUTH MEETING, Pa., Sept. 28, 2020 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, announced that the... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - September 28, 2020 Category: Pharmaceuticals Source Type: clinical trials

Khondrion Receives Rare Pediatric Disease Designation for Sonlicromanol from US FDA
September 28, 2020 -- Khondrion, a clinical-stage biopharmaceutical company discovering and developing therapies targeting mitochondrial disease, today announces that it received a rare pediatric disease (RPD) designation from the United States (US)... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - September 28, 2020 Category: Pharmaceuticals Source Type: clinical trials

Johnson & Johnson Posts Interim Results from Phase 1/2a Clinical Trial of its Janssen COVID-19 Vaccine Candidate
September 25, 2020 -- Interim analysis from the ongoing Phase 1/2a clinical trial of the Janssen COVID-19 vaccine candidate (JNJ-78436735) was posted today on the pre-print server medRxiv. The data demonstrate that a single dose of JNJ-78436735... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - September 25, 2020 Category: Pharmaceuticals Source Type: clinical trials

Scientists Discover Genetic and Immunologic Underpinnings of Some Cases of Severe COVID-19
September 24, 2020 -- New findings by scientists at the National Institutes of Health and their collaborators help explain why some people with COVID-19 develop severe disease. The findings also may provide the first molecular explanation for why... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - September 24, 2020 Category: Pharmaceuticals Source Type: clinical trials

Novavax Initiates Phase 3 Efficacy Trial of COVID-19 Vaccine in the United Kingdom
GAITHERSBURG, Md., Sept. 24, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that it has initiated its... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - September 24, 2020 Category: Pharmaceuticals Source Type: clinical trials

Telix Pharmaceuticals Submits New Drug Application to US FDA for Prostate Cancer Imaging Product
MELBOURNE, Australia and INDIANAPOLIS, Sept. 24, 2020 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX,‘Telix’, the‘Company’) today announces it has submitted a New Drug Application (NDA) to the United States... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - September 24, 2020 Category: Pharmaceuticals Source Type: clinical trials

NeuroRx Submits Request for Emergency Use Authorization for RLF-100 ™ (aviptadil) in the Treatment of Patients with Critical COVID-19 and Respiratory Failure Who Have Exhausted Approved Therapy
RADNOR, Pa., Sept. 23, 2020 /PRNewswire/— NeuroRx, Inc. has submitted a request for an Emergency Use Authorization (EUA) with the US FDA for the use of RLF-100™ aviptadil in patients who are receiving intensive care and who have... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - September 23, 2020 Category: Pharmaceuticals Source Type: clinical trials

Anti-Influenza Drug Avigan ® Tablet Meets Primary Endpoint in Phase III Clinical Trial in Japan for COVID-19 Patients
TOKYO— September 23, 2020 FUJIFILM Toyama Chemical Co., Ltd. (President: Junji Okada; hereinafter“FUJIFILM Toyama Chemical”) has announced today that primary endpoint has been met in phase III clinical trial of“Avigan... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - September 23, 2020 Category: Pharmaceuticals Source Type: clinical trials

Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen ’s COVID-19 Vaccine Candidate
NEW BRUNSWICK, N.J., September 23, 2020 – Johnson& Johnson (NYSE: JNJ) (the Company) today announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its COVID-19 vaccine candidate,... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - September 23, 2020 Category: Pharmaceuticals Source Type: clinical trials

NIH Expands Clinical Trials to Test Convalescent Plasma Against COVID-19
September 22, 2020 -- Two randomized, placebo-controlled clinical trials funded by the National Institutes of Health (NIH) are expanding enrollment to further evaluate convalescent plasma as a treatment for patients hospitalized with COVID-19.... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - September 22, 2020 Category: Pharmaceuticals Source Type: clinical trials

MacroGenics Announces Publication of Flotetuzumab Interim Phase 1/2 Clinical Trial Results in Blood
ROCKVILLE, MD, Sept. 22, 2020 (GLOBE NEWSWIRE) --  MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - September 22, 2020 Category: Pharmaceuticals Source Type: clinical trials

Daiichi Sankyo Initiates Phase 2 Study of Patritumab Deruxtecan in Patients with HER3 Expressing Advanced Colorectal Cancer
Tokyo, Basking Ridge, N.J. and Munich– (September 14, 2020) – Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced today that the first patient has been dosed in a phase 2 study evaluating patritumab deruxtecan... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - September 21, 2020 Category: Pharmaceuticals Source Type: clinical trials

Clinical Data From Full Phase 1 Cohort Of Investigational Sotorasib Published In New England Journal Of Medicine
THOUSAND OAKS, Calif., Sept. 20, 2020 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that updated data from the full Phase 1 cohort of the CodeBreaK 100 clinical study, evaluating sotorasib (proposed INN for AMG 510) in 129... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - September 21, 2020 Category: Pharmaceuticals Source Type: clinical trials

Gilead ’s Magrolimab, an Investigational Anti-CD47 Monoclonal Antibody, Receives FDA Breakthrough Therapy Designation for Treatment of Myelodysplastic Syndrome
FOSTER CITY, Calif.--(BUSINESS WIRE)--Sep. 15, 2020-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for magrolimab, a... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - September 21, 2020 Category: Pharmaceuticals Source Type: clinical trials

BioNTech to Acquire GMP Manufacturing Site to Expand COVID-19 Vaccine Production Capacity in First Half 2021
MAINZ, Germany, September 17, 2020 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX,“BioNTech” or“the Company”) today announced the signing of a share purchase agreement with Novartis AG, Basel /... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - September 17, 2020 Category: Pharmaceuticals Source Type: clinical trials

Lilly Announces Proof of Concept Data for Neutralizing Antibody LY-CoV555 in the COVID-19 Outpatient Setting
INDIANAPOLIS, Sept. 16, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced proof of concept data from an interim analysis of the BLAZE-1 clinical trial, showing a reduced rate of hospitalization for patients treated... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - September 16, 2020 Category: Pharmaceuticals Source Type: clinical trials

Novavax Announces COVID-19 Vaccine Manufacturing Agreement with Serum Institute of India, Increasing Novavax ’ Global Production Capacity to Over 2 Billion Doses Annually
GAITHERSBURG, Md., Sept. 15, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced an amendment to its... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - September 15, 2020 Category: Pharmaceuticals Source Type: clinical trials

BioNTech to Receive up to €375M in Funding from German Federal Ministry of Education and Research to Support COVID-19 Vaccine Program BNT162
MAINZ, GERMANY, September 15, 2020 — BioNTech SE (Nasdaq: BNTX,“BioNTech” or“the Company”) today announced that it will receive a grant of up to 375 million Euro from an initiative by the German Federal... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - September 15, 2020 Category: Pharmaceuticals Source Type: clinical trials

Kiniksa Announces U.S. Orphan Drug Designation for Mavrilimumab for the Treatment of Giant Cell Arteritis
HAMILTON, Bermuda, Sept. 15, 2020 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa”), a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - September 15, 2020 Category: Pharmaceuticals Source Type: clinical trials

Baricitinib in Combination with Remdesivir Reduces Time to Recovery in Hospitalized Patients
INDIANAPOLIS, Sept. 14, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) announced today initial data emerging from the Adaptive COVID-19 Treatment Trial (ACTT-2) sponsored by the National Institute of... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - September 14, 2020 Category: Pharmaceuticals Source Type: clinical trials

Vaxart Announces FDA Clearance of IND Application for Oral COVID-19 Vaccine and Provides Update on COVID-19 Program
SOUTH SAN FRANCISCO, Calif., Sept. 14, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc., a clinical-stage biotechnology company developing oral vaccines that are administered by tablet rather than by injection, today announced that the U.S.... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - September 14, 2020 Category: Pharmaceuticals Source Type: clinical trials